[144] AVANOS MEDICAL, INC. SEC Filing

Rhea-AI Filing Summary

AVNS

11/18/2025 - 11:45 AM

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	15000	165014.21	46418907	11/18/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/04/2023	Restricted Stock Vesting	Issuer			474	03/04/2023	Compensation
Common	05/07/2023	Restricted Stock Vesting	Issuer			3913	05/07/2023	Compensation
Common	06/30/2023	ESPP Purchase	Issuer			782	06/30/2023	Cash
Common	12/29/2023	ESPP Purchase	Issuer			149	12/29/2023	Cash
Common	03/04/2024	Restricted Stock Vesting	Issuer			2771	03/04/2024	Compensation
Common	03/06/2024	Restricted Stock Vesting	Issuer			709	03/06/2024	Compensation
Common	03/04/2025	Restricted Stock Vesting	Issuer			6202	03/04/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the AVNS Form 144 filing report?

The Form 144 for AVNS reports a proposed sale of 15,000 shares of common stock. The sale is to be executed through Fidelity Brokerage Services LLC on the NYSE, with an aggregate market value of $165,014.21.

How many AVNS shares are proposed to be sold under this Form 144?

The filing indicates a proposed sale of 15,000 shares of AVNS common stock, with an aggregate market value of $165,014.21 at the time indicated in the form.

When is the AVNS Form 144 sale expected to take place and on which exchange?

The notice lists an approximate sale date of 11/18/2025, and states that the 15,000 AVNS common shares are to be sold on the NYSE.

How were the AVNS shares being sold under Form 144 originally acquired?

The shares were acquired from the issuer through a mix of restricted stock vesting and employee stock purchase plan (ESPP) purchases between 03/04/2023 and 03/04/2025, with consideration described as either compensation or cash.

How many AVNS shares are shown as outstanding in the Form 144?

The securities information table shows 46,418,907 shares of AVNS common stock outstanding, which serves as a baseline figure separate from the 15,000 shares proposed for sale.

What representation does the seller make in the AVNS Form 144?

By signing the notice, the seller represents that they do not know any material adverse information about AVNS’s current or prospective operations that has not been publicly disclosed.